Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $61.51 and traded as high as $63.29. Eisai shares last traded at $61.51, with a volume of 331,800 shares trading hands.
Eisai Stock Performance
The business’s fifty day moving average price is $61.51 and its 200-day moving average price is $61.51. The stock has a market cap of $17.64 billion, a PE ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.77 and a current ratio of 2.20.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Recommended Stories
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
